VanEck Biotech ETF (BBH)
- Previous Close
154.77 - Open
154.55 - Bid 154.29 x 200
- Ask 162.61 x 100
- Day's Range
154.55 - 156.17 - 52 Week Range
142.51 - 171.05 - Volume
6,386 - Avg. Volume
7,803 - Net Assets 452.51M
- NAV 155.66
- PE Ratio (TTM) 15.75
- Yield 0.43%
- YTD Daily Total Return -5.88%
- Beta (5Y Monthly) 0.85
- Expense Ratio (net) 0.35%
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
VanEck
Fund Family
Health
Fund Category
452.51M
Net Assets
2011-12-20
Inception Date
Performance Overview: BBH
Trailing returns as of 4/26/2024. Category is Health.
People Also Watch
Holdings: BBH
Top 10 Holdings (68.04% of Total Assets)
Sector Weightings
Recent News: BBH
Research Reports: BBH
VRSN: Raising target price to $201.00
VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetAnalyst Report: Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
RatingPrice TargetRMBS: Raising target price to $67.00
RAMBUS INC has an Investment Rating of HOLD; a target price of $67.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetVRSN: Lowering target price to $201.00
VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target